Compare NRC & NMAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRC | NMAI |
|---|---|---|
| Founded | 1981 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.1M | 452.6M |
| IPO Year | 1997 | N/A |
| Metric | NRC | NMAI |
|---|---|---|
| Price | $20.04 | $13.73 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 166.3K | 125.5K |
| Earning Date | 04-28-2026 | 01-01-0001 |
| Dividend Yield | 3.86% | ★ 13.14% |
| EPS Growth | ★ 4707.69 | N/A |
| EPS | 0.14 | ★ 0.64 |
| Revenue | ★ $119,686,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $139.21 | ★ $21.77 |
| Revenue Growth | ★ 1.81 | N/A |
| 52 Week Low | $11.01 | $11.99 |
| 52 Week High | $22.79 | $14.38 |
| Indicator | NRC | NMAI |
|---|---|---|
| Relative Strength Index (RSI) | 56.38 | 46.26 |
| Support Level | $18.03 | $13.70 |
| Resistance Level | $21.33 | $13.90 |
| Average True Range (ATR) | 1.17 | 0.28 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 63.00 | 48.83 |
NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve. The group provides solutions for Patient, Consumer, Employee, and Market experiences. The group's commitment to Human Understanding helps healthcare systems get to know the patients, families, consumers, employees, and communities it on a human level.
Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund's investment objective is to provide total return through high current income and capital appreciation.